Sector and route assessment
Identify the applicable GMP framework and intended market or authority.
GMP CERTIFICATION — READINESS & GUIDANCE
Define the site and processes reviewed.
Gather procedures and process proof.
UNDERSTAND THE ASSESSMENT
Good Manufacturing Practices concern the controls used to produce and verify products consistently. The applicable framework depends on the sector, product and market; pharmaceutical GMP should not be treated as a universal certificate for every business. We help organise the scope and preparation records, while certification or regulatory decisions remain with the relevant competent body.
PLAN THE RIGHT SUPPORT
Identify the applicable GMP framework and intended market or authority.
Organise the premises, personnel and process information needed for assessment.
Review available procedures, production records and quality-control evidence.
Organise the response to findings and the evidence of corrective work.
Define the site, products and processes under review.
Bring procedures and operational evidence together.
Identify work needed beyond drafting documents.
The correct route depends on the people, activity and location involved.
Determine which GMP requirements apply to the intended operation.
Identify the premises, processes and responsible personnel.
Check the authority or certification requirements relevant to the target market.
Confirm the current framework, competent assessment body and scope for the particular case.
Choose the structure around your ownership and operating plans.
This is a starting checklist. Final requirements depend on your profile and the relevant filing procedure. Do not submit identity documents through the general enquiry form.
Identify the sector, site, products and assessment objective.
Stage 1
Organise procedures and evidence of actual implementation.
Stage 2
Identify documentation and operational actions needed.
Stage 3
Support the agreed readiness work and response records without controlling the outcome.
Stage 4
Depends on a clear scope and accessible site records.
Facility, process or training gaps may require work before assessment.
The relevant body determines its review and corrective-action process.
UNDERSTAND THE DIFFERENCE
| Workstream | Main role | What it does not replace |
|---|---|---|
| GMP readiness | Organises the site’s processes and evidence for review. | An independent regulatory or certification assessment. |
| GMP assessment or certificate | Records findings or status under the applicable framework. | Every product-specific authorisation. |
| Product or market permission | Addresses the relevant product and jurisdiction requirements. | Continuing manufacturing controls. |
No generic certificate should be presented as automatic WHO endorsement, regulatory approval or acceptance in every market. Trade Innovation provides agreed preparation support, not regulatory certification.
WHY TRADE INNOVATION
Start with your plans and available records. We’ll help organise the work into an understandable scope.
Identify the documents needed for the agreed route.
Know what information and decisions are needed from you.
Separate initial setup from continuing compliance and other licences.
CLIENT EXPERIENCES
Preview content: cards marked “Design sample” use fictional names, feedback, ratings and dates.
VIDEO GUIDES
EXPLORE OTHER BUSINESS OPTIONS
Review your proposed products, activity and premises to organise the application requirements relevant to drug or cosmetic operations.
Explore service
Review the activity, site and operating stage to identify the consent, authorisation or clearance requirements relevant to your project.
Explore service
Review your food activity, premises and current eligibility before preparing an FSSAI registration or licensing application through FoSCoS.
Explore serviceNo. The sector, products, site and intended market determine the applicable framework and acceptance requirements.
Written procedures need to reflect implemented controls and supporting records. Paperwork alone is not the same as effective operation.
Do not assume so. Licensing and other regulatory permissions require separate assessment.
No. Identify the exact assessment, issuing body and scope rather than relying on a generic WHO-related claim.
No. The competent body decides the outcome, and operational gaps may require corrective work.